BELMORA LLC FDA Approval ANDA 083559

ANDA 083559

BELMORA LLC

FDA Drug Application

Application #083559

Application Sponsors

ANDA 083559BELMORA LLC

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION3%0MEPIVACAINE HYDROCHLORIDEMEPIVACAINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1973-12-04
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1983-10-20
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1985-01-31
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1985-01-31
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1987-11-04
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1988-11-03
LABELING; LabelingSUPPL20AP1989-11-29
LABELING; LabelingSUPPL21AP1990-10-25
LABELING; LabelingSUPPL22AP1993-03-04
LABELING; LabelingSUPPL23AP1994-08-10

Submissions Property Types

SUPPL11Null0
SUPPL13Null0
SUPPL14Null0
SUPPL17Null0
SUPPL19Null0

CDER Filings

BELMORA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 83559
            [companyName] => BELMORA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"MEPIVACAINE HYDROCHLORIDE","activeIngredients":"MEPIVACAINE HYDROCHLORIDE","strength":"3%","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"MEPIVACAINE HYDROCHLORIDE","submission":"MEPIVACAINE HYDROCHLORIDE","actionType":"3%","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.